BKV three-lens brief
Evidence-based stock research on BKV. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +3.57% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved +3.57% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- P/E of 8.6 — trading at a value multiple.
- Analyst mean target $34.09 — 37% above current (11 analysts).
- Negative free cash flow last quarterly (-$697.88M).
BKV closed at $24.96 (+3.57%) as of 2026-09-11. Market cap: $2.73B. P/E (trailing) 8.6. Price is below the 50-day MA and below the 200-day MA. Positives: moved +3.57% yesterday.; p/E of 8.6 — trading at a value multiple.. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; negative free cash flow last quarterly (-$697.88M).. Last quarter: Revenue $465.54M, net income $75.81M, free cash flow -$697.88M.
Why three lenses on BKV, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BKVacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BKV" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BKV brief"></iframe>